Collagen Cross-Linking and Metabolism

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 319-334

  Robins, Simon P ^a   Brady, Jeffrey D ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882491717     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00035-5     Document Type: Chapter

References (146)

1. G. Abbiati, F. Bartucci, A. Longoni, G. Fincato, S. Galimberti, M. Rigoldi and C. Castiglioni (1993) Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: Sample relationships between 24-h and fasting early morning urine concentrations. Bone Miner 21 9-19.
2. M. Adamczyk, D.D. Johnson and R.E. Reddy (2001) Bone collagen cross-links: A convergent synthesis of (1)- deoxypyrrololine. J. Org. Chem. 66 11-19.
3. A.W. Al-Dehaimi, A. Blumsohn and R. Eastell (1999) Serum galactosyl hydroxylysine as a biochemical marker of bone resorption. Clin. Chem. 45 676-681.
4. P. Alexandersen, P. Peris, N. Guanabens, I. Byrjalsen, L. Alvarez, H. Solberg and P.A. Cloos (2005) Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone. J. Bone. Miner. Res. 20 588-595.
5. S. Apone, M.Y. Lee and D.R. Eyre (1997) Osteoclasts generate cross-linked collagen n-telopeptides (ntx) but not free pyridinolines when cultured on human bone. Bone 21 129-136.
6. A. Aruga, M. Koizumi, R. Hotta, S. Takahashi and E. Ogata (1997) Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer. Brit. J. Cancer 76 760-764.
7. L.M. Atley, J.S. Mort, M. Lalumiere and D.R. Eyre (2000) Proteolysis of human bone collagen by cathepsin K: Characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope. Bone 26 241-247.
8. S. Avnet, A. Lamolinara, N. Zini, L. Solimando, G. Quacquaruccio, D. Granchi, N.M. Maraldi, A. Giunti and N. Baldini (2006) Effects of antisense mediated inhibition of cathepsin K on human osteoclasts obtained from peripheral blood. J. Orthop. Res. 24 1699-1708.
9. A.J. Bailey, S.P. Robins and G. Balian (1974) Biological significance of the intermolecular cross-links of collagen. Nature 251 105-109.
10. A.J. Bailey, T.J. Sims, E.N. Ebbesen, J.P. Mansell, J.S. Thomsen and L. Mosekilde (1999) Age-related changes in the biochemical properties of human cancellous bone collagen: Relationship to bone strength. Calcif. Tissue Int. 65 203-210.
11. R.A. Bank, S.P. Robins, C. Wijmenga, L.J. Breslau-Siderius, A.F. Bardoel, H.A. van der Sluijs, H.E. Pruijs and J.M. TeKoppele (1999) Defective collagen cross-linking in bone, but not in ligament or cartilage, in Bruck syndrome: Indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc. Natl. Acad. Sci. USA 96 1054-1058.
12. X. Banse, J.P. Devogelaer, A. Lafosse, T.J. Sims, M. Grynpas and A.J. Bailey (2002) Cross-link profile of bone collagen correlates with structural organization of trabeculae. Bone 31 70-76.
13. X. Banse, T.J. Sims and A.J. Bailey (2002) Mechanical properties of adult vertebral cancellous bone: Correlation with collagen intermolecular cross-links. J. Bone Miner. Res. 17 1621-1628.
14. H.L. Benford, N.W. McGowan, M.H. Helfrich, M.E. Nuttall and M.J. Rogers (2001) Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28 465-473.
15. D.E. Birk, J.M. Fitch, J.P. Babiarz and T.F. Linsenmayer (1988) Collagen type I and V are present in the same fibril in avian corneal stroma. J. Cell Biol. 106 999-1008.
16. N.H. Bjarnason, E.E. Henriksen, P. Alexandersen, S. Christgau, D.B. Henriksen and C. Christiansen (2002) Mechanism of circadian variation in bone resorption. Bone 30 307-313.
17. D. Black, A. Duncan and S.P. Robins (1988) Quantitative analysis of the pyridinium cross-links of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal. Biochem. 169 197-203.
18. J.D. Brady, J. Ju and S.P. Robins (1999) Isoaspartyl bond formation within N-terminal sequences of collagen type I: Implications for their use as markers of collagen degradation. Clin. Sci. 96 209-215.
19. J.D. Brady and S.P. Robins (2001) Structural characterization of pyrrolic cross-links in collagen using a biotinylated Ehrlich's reagent. J. Biol. Chem. 276 18812-18818.
20. I. Byrjalsen, D.J. Leeming, P. Qvist, C. Christiansen and M.A. Karsdal (2007) Bone turnover and bone collagen maturation in osteoporosis: Effects of antiresorptive therapies. Osteoporos. Int. (in press)
21. H. Chanut-Delalande, A. Fichard, S. Bernocco, R. Garrone, D.J. Hulmes and F. Ruggiero (2001) Control of heterotypic fibril formation by collagen V is determined by chain stoichiometry. J. Biol. Chem. 276 24352-24359.
22. P.A. Cloos, S. Christgau, N. Lyubimova, J.J. Body, P. Qvist and C. Christiansen (2003) Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments. Breast Cancer Res. Treat 5 R103-rR109.
23. P.A. Cloos, C. Fledelius, S. Christgau, C. Christiansen, M. Engsig, P. Delmas, J.J. Body and P. Garnero (2003) Investigation of bone disease using isomerized and racemized fragments of type I collagen. Calcif. Tissue Int. 72 8-17.
24. P.A. Cloos, N. Lyubimova, H. Solberg, P. Qvist, C. Christiansen, I. Byrjalsen and S. Christgau (2004) An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone. Clin. Lab. 50 279-289.
25. P.A.C. Cloos and C. Fledelius (2000) Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: A biological clock of protein aging with clinical potential. Biochem. J. 345 473-480.
26. J.A. Clowes, R.A. Hannon, T.S. Yap, N.R. Hoyle, A. Blumsohn and R. Eastell (2002) Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 30 886-890.
27. J.A. Clowes, R.T. Robinson, S.R. Heller, R. Eastell and A. Blumsohn (2002) Acute changes of bone turnover and PTH induced by insulin and glucose: Euglycemic and hypoglycemic hyperinsulinemic clamp studies. J. Clin. Endocrinol. Metab. 87 3324-3329.
28. A. Colwell and R. Eastell (1996) The renal clearance of free and conjugated pyridinium cross-links of collagen. J. Bone Miner. Res. 11 1976-1980.
29. A. Colwell, R.G. Russell and R. Eastell (1993) Factors affecting the assay of urinary 3-hydroxy pyridinium cross-links of collagen as markers of bone resorption. Eur. J. Clin. Invest 23 341-349.
30. F.P. Coxon, K. Thompson and M.J. Rogers (2006) Recent advances in understanding the mechanism of action of bisphosphonates. Curr. Opin. Pharmacol. 6 307-312.
31. J.M. Delaisse, T.L. Andersen, M.T. Engsig, K. Henriksen, T. Troen and L. Blavier (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc. Res. Tech. 61 504-513.
32. P. Delmas (1993) Biochemical markers of bone turnover for the clinical investigation of osteoporosis. Osteoporos. Int. 3(Suppl 1), 81-86.
33. R. Eastell, A. Colwell, L. Hampton and J. Reeve (1997) Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J. Bone Miner. Res. 12 59-65.
34. I. Elomaa, P. Virkkunen, L. Risteli and J. Risteli (1992) Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br. J. Cancer 66 337-341.
35. H.A. Eriksen, C.A. Sharp, S.P. Robins, M.L. Sassi, L. Risteli and J. Risteli (2004) Differently cross-linked and uncross-linked carboxy-terminal telopeptides of type I collagen in human mineralised bone. Bone 34 720-727.
36. V. Everts, W.S. Hou, X. Rialland, W. Tigchelaar, P. Saftig, D. Bromme, B.D. Gelb and W. Beertsen (2003) Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif. Tissue Int. 73 380-386.
37. D. Eyre, P. Shao, M.A. Weis and B. Steinmann (2002) The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): Differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine. Mol. Genet. Metab. 76 211-216.
38. D.R. Eyre (1981) Cross-link maturation in bone collagen. Dev. Biochem. 22 51-55.
39. D.R. Eyre, T.J. Koob and K.P. Van Ness (1984) Quantitation of hydroxypyridinium cross-links in collagen by high-performance liquid chromatography. Anal. Biochem. 137 380-388.
40. D.R. Eyre and H. Oguchi (1980) Hydroxypyridinium cross-links of skeletal collagens: Their measurement, properties, and a proposed pathway of formation. Biochem. Biophys. Res. Commun. 92 403-410.
41. P.M. Fall, D. Kennedy, J.A. Smith, M.J. Seibel and L.G. Raisz (2000) Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men. Osteoporos. Int. 11 481-485.
42. A.M. Flanagan and T.J. Chambers (1991) Inhibition of bone resorption by bisphosphonates: Interactions between bisphosphonates, osteoclasts, and bone. Calcif. Tissue Int. 49 407-415.
43. C. Fledelius, A.H. Johnsen, P.A.C. Cloos, M. Bonde and P. Qvist (1997) Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (α1) region. J. Biol. Chem. 272 9755-9763.
44. N. Fratzl-Zelman, A. Valenta, P. Roschger, A. Nader, B.D. Gelb, P. Fratzl and K. Klaushofer (2004) Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J. Clin. Endocrinol. Metab. 89 1538-1547.
45. D. Fujimoto, T. Moriguchi, T. Ishida and H. Hayashi (1978) The structure of pyridinoline, a collagen cross-link. Biochem. Biophys. Res. Commun. 84 52-57.
46. K. Fuller, B. Kirstein and T.J. Chambers (2007) Regulation and enzymatic basis of bone resorption by human osteoclasts. Clin. Sci. (Lond). 112 567-575.
47. P. Garnero, E. Gineyts, P. Arbault, C. Christiansen and P.D. Delmas (1995) Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J. Bone Miner. Res. 10 641-649.
48. P. Garnero, C. Fledelius, E. Gineyts, C.M. Serre, E. Vignot and P.D. Delmas (1997) Decreased β-isomerization of the C-terminal telopeptide of type I collagen α1 chain in Paget's disease of bone. J. Bone Min. Res. 12 1407-1415.
49. P. Garnero, O. Borel, I. Byrjalsen, M. Ferreras, F.H. Drake, M.S. McQueney, N.T. Foged, P.D. Delmas and J.M. Delaisse (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273 32347-32352.
50. P. Garnero, O. Borel, E. Gineyts, F. Duboeuf, H. Solberg, M.L. Bouxsein, C. Christiansen and P.D. Delmas (2006) Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 38 300-309.
51. B.D. Gelb, G.P. Shi, H.A. Chapman and R.J. Desnick (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273 1236-1238.
52. E. Gineyts, P.A.C. Cloos, O. Borel, L. Grimaud, P.D. Delmas and P. Garnero (2000) Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover. Biochem. J. 345 481-485.
53. C. Giunta, A. Randolph, L.I. Al-Gazali, H.G. Brunner, M.E. Kraenzlin and B. Steinmann (2005) Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA). Am. J. Med. Genet. A. 133 158-164.
54. B. Gomez, S. Ardakani, B. Evans, L. Merrell, D. Jenkins and V. Kung (1996) Monoclonal antibody assay for free urinary pyridinium cross-links. Clin. Chem. 42 1168-1175.
55. R. Ha-Vinh, Y. Alanay, R.A. Bank, A.B. Campos-Xavier, A. Zankl, A. Superti-Furga and L. Bonafe (2004) Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Am. J. Med. Genet. A. 131A 115-120.
56. B. Han, M. Copeland, A.G. Geiser, L.V. Hale, A. Harvey, Y.L. Ma, C.S. Powers, M. Sato, J. You and J.E. Hale (2007) Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity. J. Proteome Res. 6 4218-4229.
57. Z.H. Han, S. Palnitkar, D.S. Rao, D. Nelson and A.M. Parfitt (1997) Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: Implications for mechanisms of bone loss. J. Bone Miner. Res. 12 498-508.
58. D.A. Hanson, M.A. Weis, A.M. Bollen, S.L. Maslan, F.R. Singer and D.R. Eyre (1992) A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J. Bone Miner. Res. 7 1251-1258.
59. D. Hanson and D. Eyre (1996) Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J. Biol. Chem. 271 26508-26516.
60. J. Heikkinen, M. Risteli, C. Wang, J. Latvala, M. Rossi, M. Valtavaara and R. Myllyla (2000) Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity. J. Biol. Chem. 275 36158-36163.
61. P.M. Helfman and J.L. Bada (1975) Aspartic acid racemization in tooth enamel from living humans. Proc. Natl. Acad. Sci. USA 72 2891-2894.
62. D.B. Henriksen, P. Alexandersen, N.H. Bjarnason, T. Vilsboll, B. Hartmann, E.E. Henriksen, I. Byrjalsen, T. Krarup, J.J. Holst and C. Christiansen (2003) Role of gastrointestinal hormones in postprandial reduction of bone resorption. J. Bone Miner. Res. 18 2180-2189.
63. D.B. Henriksen, P. Alexandersen, I. Byrjalsen, B. Hartmann, H.G. Bone, C. Christiansen and J.J. Holst (2004) Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2. Bone 34 140-147.
64. D.B. Henriksen, P. Alexandersen, B. Hartmann, C.L. Adrian, I. Byrjalsen, H.G. Bone, J.J. Holst and C. Christiansen (2007) Disassociation of bone resorption and formation by GLP-2: A 14-day study in healthy postmenopausal women. Bone 40 723-729.
65. K. Henriksen, D.J. Leeming, I. Byrjalsen, R.H. Nielsen, M.G. Sorensen, M.H. Dziegiel, T.J. Martin, C. Christiansen, P. Qvist and M.A. Karsdal (2007) Osteoclasts prefer aged bone. Osteoporos. Int. 18 751-759.
66. C.J. Hernandez, S.Y. Tang, B.M. Baumbach, P.B. Hwu, A.N. Sakkee, F. van der Ham, J. DeGroot, R.A. Bank and T.M. Keaveny (2005) Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone 37 825-832.
67. J.J. Holst, B. Hartmann, I.B. Gottschalck, P.B. Jeppesen, J. Miholic and D.B. Henriksen (2007) Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate. Scand. J. Gastroenterol. 42 814-820.
68. M.S. Huda, B.H. Durham, S.P. Wong, T.M. Dovey, P. McCulloch, D. Kerrigan, J.H. Pinkney, W.D. Fraser and J.P. Wilding (2007) Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects. Bone 41 406-413.
69. D.E. Hughes, K.R. Wright, H.L. Uy, A. Sasaki, T. Yoneda, G.D. Roodman, G.R. Mundy and B.F. Boyce (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Miner. Res. 10 1478-1487.
70. C.H. Jensen, M. Hansen, J. Brandt, H.B. Rasmussen, P.B. Jensen and B. Teisner (1998) Quantification of the N-terminal propeptide of human procollagen type I (PINP): Comparison of ELISA and RIA with respect to different molecular forms. Clin. Chim. Acta. 269 31-41.
71. S. Kamel, M. Brazier, V. Neri, C. Picard, L. Samson, G. Desmet and J.L. Sebert (1995) Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods. J. Bone Miner. Res. 10 1385-1392.
72. K. Kawana, M. Takahashi, H. Hoshino and K. Kushida (2002) Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause, and osteoporosis. Clin. Chim. Acta. 316 109-115.
73. D.R. Keene, L.Y. Sakai and R.E. Burgeson (1991) Human bone contains type III collagen, type VI collagen, and fibrillin: Type III collagen is present on specific fibers that may mediate attachment of tendons, ligaments, and periosteum to calcified bone cortex. J. Histochem. Cytochem. 39 59-69.
74. P.D. Kemp and J.E. Scott (1988) Ehrlich chromogens, probable cross-links in elastin and collagen. Biochem. J. 252 387-393.
75. L. Knott, J.F. Tarlton and A.J. Bailey (1997) Chemistry of collagen cross-linking: Biochemical changes in collagen during the partial mineralization of turkey leg tendon. Biochem. J. 322 535-542.
76. S. Kumar, L. Dare, J.A. Vasko-Moser, I.E. James, S.M. Blake, D.J. Rickard, S.M. Hwang, T. Tomaszek, D.S. Yamashita, R.W. Marquis, H. Oh, J.U. Jeong, D.F. Veber, M. Gowen, M.W. Lark and G. Stroup (2007) A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys. Bone 40 122-131.
77. R. Kuypers, M. Tyler, L.B. Kurth, I.D. Jenkins and D.J. Horgan (1992) Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem. J. 283 129-136.
78. D.J. Leeming, G. Delling, M. Koizumi, K. Henriksen, M.A. Karsdal, B. Li, P. Qvist, L.B. Tanko and I. Byrjalsen (2006) Alpha CTX as a biomarker of skeletal invasion of breast cancer: Immunolocalization and the load dependency of urinary excretion. Cancer Epidemiol. Biomarkers Prev. 15 1392-1395.
79. S.D. Leigh, H.S.J. Ju, R. Lundgard, G.Y. Daniloff and V. Liu (1998) Development of an immunoassay for urinary galactosylhydroxylysine. J. Immunol. Methods 220 169-178.
80. D. Luftner, D. Jozereau, S. Schildhauer, R. Geppert, C. Muller, G. Fiolka, K.D. Wernecke and K. Possinger (2005) PINP as serum marker of metastatic spread to the bone in breast cancer patients. Anticancer Res. 25 1491-1499.
81. J.P. Malone, A. George and A. Veis (2004) Type I collagen N-telopeptides adopt an ordered structure when docked to their helix receptor during fibrillogenesis. Proteins 54 206-215.
82. J. Melkko, S. Niemi, L. Risteli and J. Risteli (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin. Chem. 36 1328-1332.
83. J. Melkko, S. Kauppila, S. Niemi, L. Risteli, K. Haukipuro, A. Jukkola and J. Risteli (1996) Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin. Chem. 42 947-954.
84. D.K. Mercer, P.F. Nicol, C. Kimbembe and S.P. Robins (2003) Identification, expression, and tissue distribution of the three rat lysyl hydroxylase isoforms. Biochem. Biophys. Res. Commun. 307 803-809.
85. L. Moro, C. Modricky, N. Stagni, F. Vittur and B. de Bernard (1984) High-performance liquid chromatographic analysis of urinary hydroxylysyl glycosides as indicators of collagen turnover. Analyst. 109 1621-1622.
86. H. Murakami, N. Takahashi, T. Sasaki, N. Udagawa, S. Tanaka, I. Nakamura, D. Zhang, A. Barbier and T. Suda (1995) A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone 17 137-144.
87. J. Myllyharju and K.I. Kivirikko (2004) Collagens, modifying enzymes, and their mutations in humans, flies, and worms. Trends Genet. 20 33-43.
88. S.A. Nesbitt and M.A. Horton (1997) Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276 266-269.
89. S.A. Nesbitt and M.A. Horton (2003) Fluorescence imaging of bone-resorbing osteoclasts by confocal microscopy. Methods Mol. Med. 80 259-281.
90. Y. Nishi, L. Atley, D.E. Eyre, J.G. Edelson, A. Superti-Furga, T. Yasuda, R.J. Desnick and B.D. Gelb (1999) Determination of bone markers in pycnodysostosis: Effects of cathepsin K deficiency on bone matrix degradation. J. Bone Miner. Res. 14 1902-1908.
91. J.S. Nyman, A. Roy, R.L. Acuna, H.J. Gayle, M.J. Reyes, J.H. Tyler, D.D. Dean and X. Wang (2006) Age-related effect on the concentration of collagen cross-links in human osteonal and interstitial bone tissue. Bone 39 1210-1217.
92. P. Odetti, S. Rossi, F. Monacelli, A. Poggi, M. Cirnigliaro, M. Federici and A. Federici (2005) Advanced glycation end products and bone loss during aging. Ann. NY Acad. Sci. 1043 710-717.
93. T. Ogawa, T. Ono, M. Tsuda and Y. Kawanashi (1982) A novel fluor in insoluble collagen: A cross-linking molecule in collagen molecule. Biochem. Biophys. Res. Commun. 107 1252-1257.
94. R. Okabe, M. Inaba, K. Nakatsuka, T. Miki, H. Naka, A. Moriguchi and Y. Nishizawa (2004) Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline. J. Bone Miner. Metab. 22 127-131.
95. S. Okuno, M. Inaba, K. Kitatani, E. Ishimura, T. Yamakawa and Y. Nishizawa (2005) Serum levels of C-terminal telopeptide of type I collagen: A useful new marker of cortical bone loss in hemodialysis patients. Osteoporos. Int. 16 501-509.
96. J.P. Orgel, T.C. Irving, A. Miller and T.J. Wess (2006) Microfibrillar structure of type I collagen in situ. Proc. Natl. Acad. Sci. USA 103 9001-9005.
97. O. Ørum, M. Hansen, C. Jensen, H. Sørensen, L. Jensen, K. Hørslev-Petersen and B. Teisner (1996) Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism. Bone 19 157-163.
98. E.P. Paschalis, K. Verdelis, S.B. Doty, A.L. Boskey, R. Mendelsohn and M. Yamauchi (2001) Spectroscopic characterization of collagen cross-links in bone. J. Bone Miner. Res. 16 1821-1828.
99. E.P. Paschalis, R. Recker, E. DiCarlo, S.B. Doty, E. Atti and A.L. Boskey (2003) Distribution of collagen cross-links in normal human trabecular bone. J. Bone Miner. Res. 18 1942-1946.
100. E.P. Paschalis, E. Shane, G. Lyritis, G. Skarantavos, R. Mendelsohn and A.L. Boskey (2004) Bone fragility and collagen cross-links. J. Bone Miner. Res. 19 2000-2004.
101. D. Pollmann, S. Siepmann, R. Geppert, K.D. Wernecke, K. Possinger and D. Luftner (2007) The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Anticancer Res. 27 1853-1862.
102. S. Pornprasertsuk, W.R. Duarte, Y. Mochida and M. Yamauchi (2004) Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells. J. Bone Miner. Res. 19 1349-1355.
103. D.A. Pratt, Y. Daniloff, A. Duncan and S.P. Robins (1992) Automated analysis of the pyridinium cross-links of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal. Biochem. 207 168-175.
104. A. Randall, G. Kent, P. Garcia-Webb, C. Bhagat, D. Pearce, D. Gutteridge, R. Prince, G. Stewart, B. Stuckey, R. Will, R. Retallack, R. Price and L. Ward (1996) Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J. Bone Miner. Res. 11 1176-1184.
105. F. Rauch, M. Georg, A. Stabrey, C. Neu, W.F. Blum, T. Remer, F. Manz and E. Schoenau (2002) Collagen markers deoxypyridinoline and hydroxylysine glycosides: Pediatric reference data and use for growth prediction in growth hormone-deficient children. Clin. Chem. 48 315-322.
106. J. Rissanen, M. Suominen, Z. Peng, J. Morko, S. Rasi, J. Risteli and J. Halleen (2008) Short-term changes in serum PINP predict long-term changes in trabecular bone in rat ovariectomy model. Calcif. Tissue Int. 82 155-161.
107. J. Risteli, I. Elomaa, S. Niemi, A. Novamo and L. Risteli (1993) Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin. Chem. 39 635-640.
108. S.P. Robins (1995) Collagen cross-links in metabolic bone disease. Acta. Orthop. Scand. Suppl. 266 171-175.
109. S.P. Robins (1998) Biochemical markers of bone turnover. T.R. Arnett, B. Henderson (Eds) Methods in Bone Biology London: Chapman and Hall 229-250.
110. S.P. Robins (2006) Fibrillogenesis and maturation of collagens. M.J. Seibel, S.P. Robins, J.P. Bilezikian (Eds) Dynamics of Bone and Cartilage Metabolism: Principles and Clinical Applications San Diego: Academic Press 41-53.
111. S.P. Robins and A. Duncan (1983) Cross-linking of collagen. Location of pyridinoline in bovine articular cartilage at two sites of the molecule. Biochem. J. 215 175-182.
112. S.P. Robins and A. Duncan (1987) Pyridinium cross-links of bone collagen and their location in peptides isolated from rat femur. Biochim. Biophys. Acta. 914 233-239.
113. S.P. Robins, M. Shimokomaki and A.J. Bailey (1973) The chemistry of the collagen cross-links: Age-related changes in the reducible components of intact bovine collagen fibres. Biochem. J. 131 771-780.
114. S.P. Robins, A. Duncan and B.L. Riggs (1990) Direct measurement of free hydroxy-pyridinium cross-links of collagen in urine as new markers of bone resorption in osteoporosis. C. Christiansen, K. Overgaard (Eds) Osteoporosis 1990 Copenhagen: Osteopress ApS 465-468.
115. S.P. Robins, H. Woitge, R. Hesley, J. Ju, S. Seyedin and M.J. Seibel (1994) Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J. Bone Miner. Res. 9 1643-1649.
116. P.M. Royce and M.J. Barnes (1985) Failure of highly purified lysyl hydroxylase to hydroxylate lysyl residues in the non-helical regions of collagen. Biochem. J. 230 475-480.
117. G.J. Rucklidge, G. Milne, G.I. Riddoch and S.P. Robins (1986) Evidence for renal tubular resorption of collagen fragments from immunostaining of rat kidney with antibodies specific for denatured type I collagen. Collagen Res. Rel. 6 185-193.
118. G.J. Rucklidge, G.I. Riddoch, L.M. Williams and S.P. Robins (1988) Autoradiographic studies of the renal clearance of circulating type I collagen fragments in the rat. Collagen Rel. Res. 8 339-348.
119. H. Ruotsalainen, L. Sipila, M. Vapola, R. Sormunen, A.M. Salo, L. Uitto, D.K. Mercer, S.P. Robins, M. Risteli, A. Aszodi, R. Fassler and R. Myllyla (2006) Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes. J. Cell Sci. 119 625-635.
120. M. Sahni, H.L. Guenther, H. Fleisch, P. Collin and T.J. Martin (1993) Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J. Clin. Invest. 91 2004-2011.
121. M. Saito, K. Fujii, S. Soshi and T. Tanaka (2006) Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos. Int. 17 986-995.
122. A.M. Salo, C. Wang, L. Sipila, R. Sormunen, M. Vapola, P. Kervinen, H. Ruotsalainen, J. Heikkinen and R. Myllyla (2006) Lysyl hydroxylase 3 (LH3) modifies proteins in the extracellular space, a novel mechanism for matrix remodeling. J. Cell Physiol. 207 644-653.
123. M. Sassi, H. Eriksen, L. Risteli, S. Niemi, J. Mansell, M. Gowen and J. Risteli (2000) Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: Loss of antigenicity by treatment with cathepsin K. Bone 26 367-373.
124. M.L. Sassi, S. Aman, M. Hakala, R. Luukkainen and J. Risteli (2003) Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis. Clin. Chem. Lab. Med. 41 1038-1044.
125. J.E. Scott, E.W. Hughes and A. Shuttleworth (1981) A collagen-associated Ehrlich chromogen: A pyrrolic cross-link? Biosci. Rep. 1 611-618.
126. J.E. Scott, R. Qian, W. Henkel and R.W. Glanville (1983) An Ehrlich chromogen in collagen cross-links. Biochem. J. 209 263-264.
127. M.J. Seibel, S.P. Robins and J.P. Bilezikian (1992) Urinary pyridinium cross-links of collagen: Specific markers of bone resorption in metabolic bone disease. Trends Endocrinol. Metab. 3 263-270.
128. D.R. Sell, K.M. Biemel, O. Reihl, M.O. Lederer, C.M. Strauch and V.M. Monnier (2005) Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J. Biol. Chem. 280 12310-12315.
129. D.R. Sell and V.M. Monnier (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J. Biol. Chem. 264 21597-21602.
130. L. Sipila, H. Ruotsalainen, R. Sormunen, N.L. Baker, S.R. Lamande, M. Vapola, C. Wang, Y. Sado, A. Aszodi and R. Myllyla (2007) Secretion and assembly of type IV and VI collagens depend on glycosylation of hydroxylysines. J. Biol. Chem. 282 33381-33388.
131. B. Smedsrod, S. Johansson and H. Pertoft (1985) Studies in vivo and in vitro on the uptake and degradation of soluble collagen alpha 1(I) chains in rat liver endothelial and Kupffer cells. Biochem. J. 228 415-424.
132. K. Takaluoma, J. Lantto and J. Myllyharju (2007) Lysyl hydroxylase 2 is a specific telopeptide hydroxylase, while all three isoenzymes hydroxylate collagenous sequences. Matrix Biol. 26 396-403.
133. K. Tezuka, Y. Tezuka, A. Maejima, T. Sato, K. Nemoto, H. Kamioka, Y. Hakeda and M. Kumegawa (1994) Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem. 269 1106-1109.
134. J. Tobias, C. Laversuch, N. Wilson and S. Robins (1996) Neridronate preferentially suppresses the urinary excretion of peptide-bound deoxypyridinoline in postmenopausal women. Calcif. Tissue Int. 59 407-409.
135. P. Trivedi, J. Risteli, L. Risteli, P. Hindmarsh, C. Brook and A. Mowat (1991) Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr. Res. 30 276-280.
136. K. Uzawa, W.J. Grzesik, T. Nishiura, S.A. Kuznetsov, P.G. Robey, D.A. Brenner and M. Yamauchi (1999) Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. J. Bone Miner. Res. 14 1272-1280.
137. A.J. van der Slot, A.M. Zuurmond, A.F. Bardoel, C. Wijmenga, H.E. Pruijs, D.O. Sillence, J. Brinckmann, D.J. Abraham, C.M. Black, N. Verzijl, J. DeGroot, R. Hanemaaijer, J.M. TeKoppele, T.W. Huizinga and R.A. Bank (2003) Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J. Biol. Chem. 278 40967-40972.
138. A.J. van der Slot, A.M. Zuurmond, A.J. van den Bogaerdt, M.M. Ulrich, E. Middelkoop, W. Boers, H. Karel Ronday, J. DeGroot, T.W. Huizinga and R.A. Bank (2004) Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. Matrix Biol. 23 251-257.
139. S. Viguet-Carrin, J.P. Roux, M.E. Arlot, Z. Merabet, D.J. Leeming, I. Byrjalsen, P.D. Delmas and M.L. Bouxsein (2006) Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 39 1073-1079.
140. L.C. Walker, M.A. Overstreet and H.N. Yeowell (2005) Tissue-specific expression and regulation of the alternatively-spliced forms of lysyl hydroxylase 2 (LH2) in human kidney cells and skin fibroblasts. Matrix Biol. 23 515-523.
141. X. Wang, X. Shen, X. Li and C.M. Agrawal (2002) Age-related changes in the collagen network and toughness of bone. Bone 31 1-7.
142. A. Wojtowicz, A. Dziedzic Goclawska, A. Kaminski, W. Stachowicz, K. Wojtowicz, S.C. Marks Jr. and M. Yamauchi (1997) Alteration of mineral crystallinity and collagen cross-linking of bones in osteopetrotic toothless (tl/tl) rats and their improvement after treatment with colony stimulating factor-1. Bone 20 127-132.
143. J. Wu, D.P. Reinhardt, C. Batmunkh, W. Lindenmaier, R.K. Far, H. Notbohm, N. Hunzelmann and J. Brinckmann (2006) Functional diversity of lysyl hydroxylase 2 in collagen synthesis of human dermal fibroblasts. Exp. Cell Res. 312 3485-3494.
144. K. Yoshihara, N. Mochidome, Y. Shida, Y. Hayakawa and M. Nagata (1993) Pre-column derivatization and its optimum conditions for quantitative determination of urinary hydroxylysine glycosides by high-performance liquid chromatography. Biol. Pharm. Bull. 16 604-607.
145. V. Zikan and J.J. Stepan (2002) Plasma type 1 collagen cross-linked C-telopeptide: A sensitive marker of acute effects of salmon calcitonin on bone resorption. Clin. Chim. Acta 316 63-69.
146. A.M. Zuurmond, A.J. van der Slot-Verhoeven, E.A. van Dura, J. De Groot and R.A. Bank (2005) Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: Implications for collagen cross-linking and treatment of fibrosis. Matrix Biol. 24 261-270.